Position in ARGX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$164,367,443
+$54,209,232 QoQ
Shares Held
177,164
+17.4% QoQ
Ownership
0.285%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#27
of 504 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Legal & General Group Plc holds $3,286,710,193 across 292 Biotechnology names. ARGX ranks #6 (5.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,870,015 | $928,892,550 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
759,971 | $473,872,316 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
924,561 | $278,320,596 | |
| 4 | RPRX |
Royalty Pharma plc
|
3,800,504 | $213,094,258 | |
| 5 | INCY |
Incyte Corp
|
1,605,980 | $182,053,892 | |
| 6 | ARGX |
Argenx SE
This page
|
177,164 | $164,367,443 | |
| 7 | INSM |
INSMED Inc
|
826,431 | $88,114,072 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
381,366 | $71,422,223 |
All Filings in ARGX
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $164,367,443 | 177,164 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $110,158,211 | 150,850 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $121,395,336 | 144,355 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $109,615,428 | 148,619 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $69,348,436 | 125,809 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $67,528,244 | 114,094 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $69,476,550 | 112,970 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $59,386,489 | 109,553 | Shares | Defined | 2025-02-28 | |
| 2024-06-30 | $46,357,450 | 107,798 | Shares | Defined | 2025-05-29 | |
| 2024-03-31 | $31,927,542 | 81,092 | Shares | Defined | 2025-05-29 | |
| 2023-12-31 | $29,788,429 | 78,302 | Shares | Defined | 2025-05-29 | |
| 2023-09-30 | $31,652,122 | 64,382 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $23,925,524 | 61,390 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $19,063,055 | 51,165 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $18,709,276 | 49,387 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $14,098,698 | 39,934 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $10,857,185 | 28,656 | Shares | Defined | 2022-08-22 | |
| No filing history on record for this holder in this stock. | ||||||